Healthy volunteers test new Drug's safety in Early-Stage trial
NCT ID NCT04314206
First seen Jan 06, 2026 · Last updated May 08, 2026 · Updated 24 times
Summary
This early-stage study tested the safety of an experimental drug called VNRX-5024 in 36 healthy adults aged 18 to 55. Participants received either a single dose or multiple doses over 10 days, and researchers monitored for side effects and how the drug moved through the body. The goal was to gather safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PRA Health Sciences - Early Development Services
Groningen, Netherlands
Conditions
Explore the condition pages connected to this study.